Total Funding
77
26
Total FundingPost-IPO Equity raised
Growth Score
-7 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1038993
Intellect Neurosciences is engaged in the R&D of disease-modifying drugs for the prevention of neurological disorders such as Alzheimer's.
Elliot Maza: Consulting Chief Financial OfficerPast Role: Biozone Pharmaceuticals, Chief Executive Officer
About the Company
Intellect Neurosciences Inc. is a New York based biopharmaceutical company engaged in the discovery and development of a new breed of innovative “disease-modifying” therapeutic drugs designed to slow, arrest and ultimately prevent Alzheimer's disease and other serious neurological disorders.
